Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Journal of Medicinal Chemistry · 13.02.2025 · 68 (3) · 2377-2402
DOI: 10.1021/acs.jmedchem.4c03049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.01.2025. Verfasst von Zhonghua Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Chinese Medical Sciences, Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan Univers…. Hauptthemen laut MEDLINE: Alzheimer Disease, Biological Products, Neuroprotective Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 202 Literaturangaben. Gefördert von: Science and Technology Department of Henan Province, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative condition marked by memory loss and cognitive decline. With current treatments offering limited effectiveness, researchers are turning to natural products that can target various aspects of AD pathology. Clinically approved natural products, such as galantamine and huperzine A, have shown success in AD treatments. Furthermore, compounds such as epigallocatechin gallate, quercetin, and resveratrol are in clinical trials. This Perspective examines nearly 100 natural compounds with promising neuroprotective effects in preclinical and clinical studies. These compounds exhibit diverse pharmacological actions that help to prevent neurodegeneration while improving cognitive functions. Their unique structures further enhance their biological activities, making them promising candidates for drug discovery. This Perspective stresses the importance of further clinical research to maximize the medical benefits of these compounds and highlights their potential as innovative remedies for AD. Continued exploration of these compounds is crucial to fully leverage their capabilities in combating AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Academy of Chinese Medical Sciences, Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- Tianjian Laboratory of Advanced Biomedical Sciences, Institute of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou 450000, China.
- College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China.
ORCID-Profile: Bin Yu
Förderung
- Science and Technology Department of Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Li, Z., Zhang, Z., & Yu, B. (2025). Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease. Journal of Medicinal Chemistry, 68(3), 2377-2402. https://doi.org/10.1021/acs.jmedchem.4c03049
Vancouver
Li Z, Zhang Z, Yu B. Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease. Journal of Medicinal Chemistry. 2025;68(3):2377-2402. doi:10.1021/acs.jmedchem.4c03049
BibTeX
@article{Li2025,
author = {Li, Zhonghua and Zhang, Zhenqiang and Yu, Bin},
title = {Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {3},
pages = {2377--2402},
doi = {10.1021/acs.jmedchem.4c03049}
}
EUVIMED